RadNet Inc. (RDNT), a national leader in providing high-quality, cost-effective diagnostic imaging services, saw its stock plunge 9.72% in the after-hours session on Thursday. This sharp decline came after the company provided its financial guidance for the fiscal year 2025.
According to the guidance, RadNet expects to generate revenue in the range of $1.825 billion to $1.875 billion for FY25. This range fell short of the consensus estimate of $1.96 billion, disappointing investors and analysts who had anticipated stronger revenue growth.
While the company also provided guidance for adjusted EBITDA of $265 million to $273 million for FY25, the lack of a consensus estimate for this metric makes it difficult to assess whether the guidance met or missed expectations.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
No relevant data is available
If the download button clicks without skipping, click on the top right menu and select "Open in Browser."